110 related articles for article (PubMed ID: 28042953)
1. Cervical small cell neuroendocrine tumor mutation profiles via whole exome sequencing.
Cho SY; Choi M; Ban HJ; Lee CH; Park S; Kim H; Kim YS; Lee YS; Lee JY
Oncotarget; 2017 Jan; 8(5):8095-8104. PubMed ID: 28042953
[TBL] [Abstract][Full Text] [Related]
2. Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
Bellone S; Jeong K; Halle MK; Krakstad C; McNamara B; Greenman M; Mutlu L; Demirkiran C; Hartwich TMP; Yang-Hartwich Y; Zipponi M; Buza N; Hui P; Raspagliesi F; Lopez S; Paolini B; Milione M; Perrone E; Scambia G; Altwerger G; Ravaggi A; Bignotti E; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Quick CM; Angioli R; Terranova C; Zaidi S; Nandi S; Alexandrov LB; Siegel ER; Choi J; Schlessinger J; Santin AD
Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2321898121. PubMed ID: 38625939
[TBL] [Abstract][Full Text] [Related]
3. Genomic alterations in neuroendocrine cancers of the ovary.
Yaghmour G; Prouet P; Wiedower E; Jamy OH; Feldman R; Chandler JC; Pandey M; Martin MG
J Ovarian Res; 2016 Aug; 9(1):52. PubMed ID: 27566252
[TBL] [Abstract][Full Text] [Related]
4. NETs: organ-related epigenetic derangements and potential clinical applications.
Cives M; Simone V; Rizzo FM; Silvestris F
Oncotarget; 2016 Aug; 7(35):57414-57429. PubMed ID: 27418145
[TBL] [Abstract][Full Text] [Related]
5. Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.
Francis JM; Kiezun A; Ramos AH; Serra S; Pedamallu CS; Qian ZR; Banck MS; Kanwar R; Kulkarni AA; Karpathakis A; Manzo V; Contractor T; Philips J; Nickerson E; Pho N; Hooshmand SM; Brais LK; Lawrence MS; Pugh T; McKenna A; Sivachenko A; Cibulskis K; Carter SL; Ojesina AI; Freeman S; Jones RT; Voet D; Saksena G; Auclair D; Onofrio R; Shefler E; Sougnez C; Grimsby J; Green L; Lennon N; Meyer T; Caplin M; Chung DC; Beutler AS; Ogino S; Thirlwell C; Shivdasani R; Asa SL; Harris CR; Getz G; Kulke M; Meyerson M
Nat Genet; 2013 Dec; 45(12):1483-6. PubMed ID: 24185511
[TBL] [Abstract][Full Text] [Related]
6. Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis.
Chang MT; Penson A; Desai NB; Socci ND; Shen R; Seshan VE; Kundra R; Abeshouse A; Viale A; Cha EK; Hao X; Reuter VE; Rudin CM; Bochner BH; Rosenberg JE; Bajorin DF; Schultz N; Berger MF; Iyer G; Solit DB; Al-Ahmadie HA; Taylor BS
Clin Cancer Res; 2018 Apr; 24(8):1965-1973. PubMed ID: 29180607
[No Abstract] [Full Text] [Related]
7. Single-Cell Transcriptome Analysis of Small Cell Neuroendocrine Carcinoma of the Endometrium Reveals
Zhong C; Guo YE; Yang Q; Song Y; Wang T; Cai B; Chen H; Du H; Wan J; Liu Y; Li Y; Wan X
Front Biosci (Landmark Ed); 2024 Mar; 29(3):100. PubMed ID: 38538277
[TBL] [Abstract][Full Text] [Related]
8. Identification of somatic alterations in lipoma using whole exome sequencing.
Kanojia D; Dakle P; Mayakonda A; Parameswaran R; Puhaindran ME; Min VLK; Madan V; Koeffler P
Sci Rep; 2019 Oct; 9(1):14370. PubMed ID: 31591430
[TBL] [Abstract][Full Text] [Related]
9. Emerging role of mutations in epigenetic regulators including MLL2 derived from The Cancer Genome Atlas for cervical cancer.
Li X
BMC Cancer; 2017 Apr; 17(1):252. PubMed ID: 28390392
[TBL] [Abstract][Full Text] [Related]
10. Genomic analysis of atypical fibroxanthoma.
Lai K; Harwood CA; Purdie KJ; Proby CM; Leigh IM; Ravi N; Mully TW; Brooks L; Sandoval PM; Rosenblum MD; Arron ST
PLoS One; 2017; 12(11):e0188272. PubMed ID: 29141020
[TBL] [Abstract][Full Text] [Related]
11. Multi-omic dataset of patient-derived tumor organoids of neuroendocrine neoplasms.
Alcala N; Voegele C; Mangiante L; Sexton-Oates A; Clevers H; Fernandez-Cuesta L; Dayton TL; Foll M
Gigascience; 2024 Jan; 13():. PubMed ID: 38451475
[TBL] [Abstract][Full Text] [Related]
12. radioGWAS links radiome to genome to discover driver genes with somatic mutations for heterogeneous tumor image phenotype in pancreatic cancer.
Zheng D; Grandgenett PM; Zhang Q; Baine M; Shi Y; Du Q; Liang X; Wong J; Iqbal S; Preuss K; Kamal A; Yu H; Du H; Hollingsworth MA; Zhang C
Sci Rep; 2024 May; 14(1):12316. PubMed ID: 38811597
[TBL] [Abstract][Full Text] [Related]
13. Advancements in the Understanding of Small-Cell Neuroendocrine Cervical Cancer: Where We Stand and What Lies Ahead.
Wang Y; Qiu H; Lin R; Hong W; Lu J; Ling H; Sun X; Yang C
J Pers Med; 2024 Apr; 14(5):. PubMed ID: 38793044
[TBL] [Abstract][Full Text] [Related]
14. Author Correction: Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues.
Feng Z; He X; Zhang X; Wu Y; Xing B; Knowles A; Shan Q; Miller S; Hojnacki T; Ma J; Katona BW; Gade TPF; Siegel DL; Schrader J; Metz DC; June CH; Hua X
Nat Cancer; 2024 Apr; 5(4):691. PubMed ID: 38605236
[No Abstract] [Full Text] [Related]
15. Next-generation Sequencing Reveals Recurrent Somatic Mutations in Small Cell Neuroendocrine Carcinoma of the Uterine Cervix.
Xing D; Zheng G; Schoolmeester JK; Li Z; Pallavajjala A; Haley L; Conner MG; Vang R; Hung CF; Wu TC; Ronnett BM
Am J Surg Pathol; 2018 Jun; 42(6):750-760. PubMed ID: 29505425
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive genomic variation profiling of cervical intraepithelial neoplasia and cervical cancer identifies potential targets for cervical cancer early warning.
Huang J; Qian Z; Gong Y; Wang Y; Guan Y; Han Y; Yi X; Huang W; Ji L; Xu J; Su M; Yuan Q; Cui S; Zhang J; Bao C; Liu W; Chen X; Zhang M; Gao X; Wu R; Zhang Y; Xu H; Zhu S; Zhu H; Yang L; Xu X; Zhou P; Liang Z
J Med Genet; 2019 Mar; 56(3):186-194. PubMed ID: 30567904
[TBL] [Abstract][Full Text] [Related]
17. Comparative genomics of high grade neuroendocrine carcinoma of the cervix.
Hillman RT; Cardnell R; Fujimoto J; Lee WC; Zhang J; Byers LA; Ramalingam P; Leitao M; Swisher E; Futreal PA; Frumovitz M
PLoS One; 2020; 15(6):e0234505. PubMed ID: 32544169
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine carcinoma of the cervix: a systematic review of the literature.
Tempfer CB; Tischoff I; Dogan A; Hilal Z; Schultheis B; Kern P; Rezniczek GA
BMC Cancer; 2018 May; 18(1):530. PubMed ID: 29728073
[TBL] [Abstract][Full Text] [Related]
19. Treatment of neuroendocrine carcinoma of the cervix with a PARP inhibitor based on next generation sequencing.
Rose PG; Sierk A
Gynecol Oncol Rep; 2019 Nov; 30():100499. PubMed ID: 31649992
[TBL] [Abstract][Full Text] [Related]
20. Genomics of High-Grade Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumor with High-Grade Features (G3 NET) and Neuroendocrine Carcinomas (NEC) of Various Anatomic Sites.
Uccella S; La Rosa S; Metovic J; Marchiori D; Scoazec JY; Volante M; Mete O; Papotti M
Endocr Pathol; 2021 Mar; 32(1):192-210. PubMed ID: 33433884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
